Earl L Yager insider trades: Chad Therapeutics (CTU) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Earl reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 15, 2006 | CTU | ↑ Buy | 10,000 | $1.53 | $15K | Direct | Aug 15, 2006 (0d) |
| Jul 31, 2006 | CTU | ↑ Buy | 4,297 | $2.79 | $12K | Retirement Plan | Aug 15, 2006 (15d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Earl L Yager's insider trades
Earl L Yager is President and CEO at Chad Therapeutics (CTU). Since Jul 31, 2006, Earl has reported 2 open-market purchases worth $27K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CTU insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.